[go: up one dir, main page]

EP1737379A4 - Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation - Google Patents

Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation

Info

Publication number
EP1737379A4
EP1737379A4 EP05767563A EP05767563A EP1737379A4 EP 1737379 A4 EP1737379 A4 EP 1737379A4 EP 05767563 A EP05767563 A EP 05767563A EP 05767563 A EP05767563 A EP 05767563A EP 1737379 A4 EP1737379 A4 EP 1737379A4
Authority
EP
European Patent Office
Prior art keywords
diabetics
methods
type
stents
bioactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05767563A
Other languages
German (de)
English (en)
Other versions
EP1737379A2 (fr
Inventor
Kenneth W Carpenter
William G Turnell
Kristen M Defife
Kathryn A Grako
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivas LLC
Original Assignee
Medivas LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivas LLC filed Critical Medivas LLC
Publication of EP1737379A2 publication Critical patent/EP1737379A2/fr
Publication of EP1737379A4 publication Critical patent/EP1737379A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Peptides Or Proteins (AREA)
EP05767563A 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation Withdrawn EP1737379A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55993704P 2004-04-05 2004-04-05
PCT/US2005/011231 WO2005097186A2 (fr) 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation

Publications (2)

Publication Number Publication Date
EP1737379A2 EP1737379A2 (fr) 2007-01-03
EP1737379A4 true EP1737379A4 (fr) 2011-08-17

Family

ID=35125623

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05767563A Withdrawn EP1737379A4 (fr) 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation

Country Status (6)

Country Link
EP (1) EP1737379A4 (fr)
JP (1) JP2007532185A (fr)
CN (1) CN1984620B (fr)
AU (1) AU2005231458A1 (fr)
CA (1) CA2562018A1 (fr)
WO (1) WO2005097186A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160287708A9 (en) * 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
JP2007517550A (ja) 2004-01-02 2007-07-05 アドヴァンスド カーディオヴァスキュラー システムズ， インコーポレイテッド 高比重リポ蛋白をコーティングした医療デバイス
US8163269B2 (en) * 2004-04-05 2012-04-24 Carpenter Kenneth W Bioactive stents for type II diabetics and methods for use thereof
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
JP5178520B2 (ja) 2005-09-22 2013-04-10 メディバス エルエルシー 固体ポリマー送達組成物およびその使用法
WO2007067744A2 (fr) * 2005-12-07 2007-06-14 Medivas, Llc Procédé destiné à assembler une composition d'administration polymère-agent biologique
WO2007133616A2 (fr) * 2006-05-09 2007-11-22 Medivas, Llc Polymères hydrosolubles biodégradables
US7572625B2 (en) 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
EP2101683A4 (fr) * 2007-01-11 2014-12-03 Robert Lamar Bjork Jr Endoprothèse coronaire à élution de médicaments multiples pour intervention coronarienne percutanée
JP2010533548A (ja) * 2007-07-17 2010-10-28 メディバス エルエルシー 生体吸収性エラストマー動脈支持装置および使用方法
US20090074831A1 (en) * 2007-09-18 2009-03-19 Robert Falotico LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
DE102008027095A1 (de) * 2008-06-06 2009-12-17 Siemens Aktiengesellschaft Interventionsvorrichtung zur Sammlung von biologischem Material und Verfahren zu ihrer Herstellung
CN101879102B (zh) * 2009-05-07 2014-07-09 上海微创医疗器械（集团）有限公司 一种凹槽携载式涂层可降解型药物洗脱支架
WO2011045443A1 (fr) * 2009-10-16 2011-04-21 Dsm Ip Assets B.V. Revêtements comprenant du polyesteramide contenant des motifs bis(alpha-aminodiesters de diols)
US9963549B2 (en) 2011-06-23 2018-05-08 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US20140220017A1 (en) 2011-09-23 2014-08-07 Universitat Stuttgart Serum half-life extension using igbd
US9220759B2 (en) 2012-02-23 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
US9220584B2 (en) 2012-03-30 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a stent and locally administered adjunctive therapy
WO2014096339A1 (fr) * 2012-12-20 2014-06-26 Dsm Ip Assets B.V. Revêtement comprenant des copolymères de polyesteramide pour l'administration de médicament
WO2016097297A1 (fr) 2014-12-18 2016-06-23 Dsm Ip Assets B.V. Système d'administration de médicament pour administration de médicaments sensibles aux acides
WO2021110474A1 (fr) * 2019-12-04 2021-06-10 Cortronik GmbH Fibres hybrides polymères gonflables pour un manchon d'une endoprothèse intraluminale

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280760B1 (en) * 1997-05-22 2001-08-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung Peptide-coated implants and methods for producing same
US20030012816A1 (en) * 1999-09-02 2003-01-16 West Jennifer L Nitric oxide-producing hydrogel materials
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2004075781A2 (fr) * 2003-02-26 2004-09-10 Medivas, Llc Endoprotheses vasculaires bioactives et leur mode d'emploi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
EP1267926A2 (fr) * 2000-03-17 2003-01-02 Millennium Pharmaceuticals, Inc. Methode d'inhibition de la stenose et de la restenose
JP2001276210A (ja) * 2000-03-28 2001-10-09 Unitika Ltd 抗菌性医療用具及びその製造方法
GB0103668D0 (en) * 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
IL156887A0 (en) * 2001-02-16 2004-02-08 Jomed Gmbh Implants with fk506
US20030064053A1 (en) * 2001-08-31 2003-04-03 Shengjiang Liu Multivalent protein conjugate with multiple ligand-binding domains of receptors
CN1303947C (zh) * 2001-12-13 2007-03-14 华东理工大学 药物洗脱性心血管支架及其制备方法
CN100455275C (zh) * 2002-02-06 2009-01-28 祥丰医疗有限公司 包覆有可促进内皮细胞的黏附和分化的包衣的医疗装置
JP2003320036A (ja) * 2002-05-01 2003-11-11 Terumo Corp ステント
CN101005812A (zh) * 2003-05-07 2007-07-25 先进生物假体表面有限公司 可植入性金属移植物及其制造方法
PL1644509T3 (pl) * 2003-07-17 2007-10-31 Bayerische Julius Maximilians Univ Wuerzburg Zastosowanie związanej z FAK nie-kinazy do wytwarzania leku do hamowania stenozy i restenozy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280760B1 (en) * 1997-05-22 2001-08-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung Peptide-coated implants and methods for producing same
US20030012816A1 (en) * 1999-09-02 2003-01-16 West Jennifer L Nitric oxide-producing hydrogel materials
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2004075781A2 (fr) * 2003-02-26 2004-09-10 Medivas, Llc Endoprotheses vasculaires bioactives et leur mode d'emploi

Also Published As

Publication number Publication date
WO2005097186A3 (fr) 2006-09-14
WO2005097186A2 (fr) 2005-10-20
CN1984620B (zh) 2011-03-30
EP1737379A2 (fr) 2007-01-03
AU2005231458A1 (en) 2005-10-20
CA2562018A1 (fr) 2005-10-20
JP2007532185A (ja) 2007-11-15
CN1984620A (zh) 2007-06-20

Similar Documents

Publication Publication Date Title
EP1868656A4 (fr) Stents bioactif pour diabétiques de type ii et méthodes pour l utiliser
EP1737379A4 (fr) Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation
EP1603485A4 (fr) Endoprotheses vasculaires bioactives et leur mode d'emploi
IL182117A0 (en) Stent
ZAA200500081S (en) Prosthetic article
EG25218A (en) Simple disposable absorbent article.
GB2420499B (en) Spinal prostheses
PL1827335T3 (pl) Wyrób chłonny
PL1827336T5 (pl) Wyrób chłonny
EP1818031A4 (fr) Article absorbant
EG24514A (en) Absorbent article with lotion-containing topsheet
IL179700A0 (en) Ocular implant and methods for making and using same
IL182915A0 (en) Inter-facet implant
GB0411360D0 (en) Implant
ZA200703851B (en) Intervertébral implant
ZA200709266B (en) Human GLP-1 mimetibodies, compositions, methods and uses
EP1814499A4 (fr) Main artificielle
GB0400571D0 (en) Implant
EP1787676A4 (fr) Endoprothese vasculaire se plaçant dans le corps
GB0426841D0 (en) Medical implant
PL2279715T5 (pl) Artykuł chłonny dla osób nietrzymających moczu
TWI369197B (en) Absorbent article
TWI350164B (en) Absorbent article
GB2411839B (en) Prosthesis
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061103

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110719

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20110713BHEP

Ipc: A61F 2/82 20060101ALI20110713BHEP

Ipc: A61F 2/06 20060101ALI20110713BHEP

Ipc: A61F 2/04 20060101ALI20110713BHEP

Ipc: A61F 2/02 20060101ALI20110713BHEP

Ipc: A61F 2/00 20060101AFI20110713BHEP

17Q First examination report despatched

Effective date: 20120726

18D Application deemed to be withdrawn

Effective date: 20121102

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

R18D Application deemed to be withdrawn (corrected)

Effective date: 20121101